Quantitative Investment Management LLC Makes New $2 Million Investment in Baxter International Inc. $BAX

Quantitative Investment Management LLC bought a new position in Baxter International Inc. (NYSE:BAX) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 88,021 shares of the medical instruments supplier’s stock, valued at approximately $2,004,000.

Other institutional investors have also modified their holdings of the company. CoreFirst Bank & Trust bought a new position in shares of Baxter International during the second quarter worth about $27,000. MTM Investment Management LLC bought a new stake in Baxter International in the second quarter valued at about $30,000. CYBER HORNET ETFs LLC bought a new stake in Baxter International in the second quarter valued at about $40,000. MUFG Securities EMEA plc acquired a new stake in Baxter International during the second quarter valued at approximately $46,000. Finally, Motco lifted its holdings in Baxter International by 374.7% during the 3rd quarter. Motco now owns 3,071 shares of the medical instruments supplier’s stock worth $70,000 after buying an additional 2,424 shares during the last quarter. Institutional investors and hedge funds own 90.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on BAX. Wall Street Zen lowered Baxter International from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Citigroup dropped their price target on Baxter International from $21.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday. Evercore reduced their price objective on Baxter International from $24.00 to $23.00 in a research note on Monday, January 5th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Baxter International in a report on Wednesday, January 21st. Finally, The Goldman Sachs Group lowered their target price on shares of Baxter International from $21.00 to $17.00 and set a “neutral” rating for the company in a research note on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $19.90.

Baxter International Stock Performance

Shares of BAX stock opened at $17.99 on Friday. The company has a market cap of $9.25 billion, a P/E ratio of -9.72, a PEG ratio of 1.26 and a beta of 0.58. The business has a 50 day moving average of $20.06 and a two-hundred day moving average of $20.69. Baxter International Inc. has a 52 week low of $17.00 and a 52 week high of $35.03. The company has a quick ratio of 1.56, a current ratio of 2.31 and a debt-to-equity ratio of 1.55.

Baxter International (NYSE:BAX) last announced its quarterly earnings results on Thursday, February 12th. The medical instruments supplier reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.09). Baxter International had a positive return on equity of 16.95% and a negative net margin of 8.51%.The company had revenue of $2.97 billion for the quarter, compared to analyst estimates of $2.82 billion. During the same quarter in the previous year, the company posted $0.58 earnings per share. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.850-2.050 EPS. As a group, analysts anticipate that Baxter International Inc. will post 2.48 EPS for the current year.

Baxter International Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Friday, February 27th will be given a $0.01 dividend. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.04 annualized dividend and a yield of 0.2%. Baxter International’s dividend payout ratio (DPR) is currently -2.16%.

Baxter International Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.